Key Takeaways
- Clinical Bottom Line
- The Transjugular Intrahepatic Portosystemic Shunt
Clinical Bottom Line
| TIPS Indication | Procedural Goal | Contraindications |
|---|---|---|
| Pre-emptive (Early) TIPS | Preventing rebleeding in Child-Pugh C (<14) patients post-variceal bleed. | Severe heart failure (high right-sided pressures) or severe hepatic encephalopathy. |
| Refractory Ascites | Decompressing portal pressures to reverse diuretic resistance and HRS. | Advanced sarcopenia or severe right ventricular dysfunction. |
| Salvage TIPS | Desperate, emergent decompression after failed endoscopic hemostasis. | Usually deployed when balloon tamponade (Blakemore) is the only bridge available. |
The Transjugular Intrahepatic Portosystemic Shunt
TIPS is a highly complex interventional radiology procedure designed to artificially bypass the fibrotic, high-resistance cirrhotic liver. By deploying an expandable PTFE-covered stent directly between the high-pressure portal vein and the low-pressure hepatic vein, portal hypertension is instantly mechanically relieved.
The Shift to Early TIPS
Historically utilized purely as a desperate salvage maneuver for uncontrollable variceal bleeding, 2026 clinical guidelines strongly advocate for “early” or “pre-emptive” TIPS. In patients presenting with acute variceal bleeding who possess a high risk of failure (Child-Pugh Class C score 10-13, or Class B with active bleeding on endoscopy), deploying a TIPS within 72 hours of admission dramatically improves ultimate survival compared to repeated rounds of endoscopic banding. However, clinicians must meticulously balance the relief of portal pressures against the guaranteed exacerbation of severe hepatic encephalopathy (HE) resulting from bypassing the liver’s ammonia-clearing capacity.
Clinical guidelines summarized by the Gastroscholar Research Team. Last updated: 2026. This article is intended for physicians.
